Molecular Insights on the Reduction‐Dependent Electronic Modulation of Graphene Oxide Surface Toward Reactivity and Acetylcholinesterase Inhibition of Alzheimer’s Drugs
- 5 November 2026
- journal article
- Published by Wiley in Chemphyschem
- Vol. 27 (21)
Abstract
Assessing the chemistry of drug molecules at nanointerfaces offers opportunities for designing advanced therapeutic materials. The systematic reduction of oxygen‐containing functional groups on graphene oxide (GO) surface from 49% to 19% significantly enhances acetylcholinesterase (AChE) inhibition activity of Alzheimer’s disease drugs, huperzine A (HUP) and tacrine (TAC) by 10.44% and 27.87%, respectively. Molecular dynamics simulations combined with protein tunnel analysis reveal that shrinking of “bottleneck radius” in the AChE active site gorge due to adsorption on reduced GO surface promotes enhanced AChE inhibition. Additionally, significant increase in antioxidant activity of HUP and TAC (6.94% and 8.81%, respectively). The results are also consistent for the benchmark phenolic and nonphenolic model antioxidant systems represented by gallic acid and α‐terpinene, respectively. Notably, highly reduced GO induces a SOMO–HOMO inversion, indicating an extensive electronic reorganization at the interface that leads to the stability of surface‐bound radical species. These results establish a direct correlation between the extent of GO surface reduction, electronic structure, and molecular reactivity, providing a mechanistic framework for tuning nano–bio interactions. Looking from the broader perspective, this work offers a rational basis for the design of multifunctional GO‐based nanomaterials for applications in catalysis, radical chemistry, and neurotherapeutics.Keywords
Funding Information
- UGC-DAE Consortium for Scientific Research, University Grants Commission (CRS/2023‐24/03/1211)
- Council of Scientific and Industrial Research, India (09/0347(24914)/2025‐EMR‐I)
This publication has 51 references indexed in Scilit:
- Recent advances in the therapeutic insights of thiazole scaffolds as acetylcholinesterase inhibitorsEuropean Journal of Medicinal Chemistry, 2025
- Loading α-helical peptide drugs onto nanotubes: Influence of surface curvature and van der Waals/electrostatic interactionsApplied Surface Science, 2025
- Graphene oxide enriched with oxygen-containing groups: on the way to an increase of antioxidant activity and biocompatibilityColloids and Surfaces B: Biointerfaces, 2022
- Crossing the blood–brain barrier with graphene nanostructuresMaterials Today, 2021
- Emerging roles of oxidative stress in brain aging and Alzheimer's diseaseNeurobiology of Aging, 2021
- The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer diseaseFree Radical Biology and Medicine, 2021
- Towards the development of antioxidant-wrapped graphene-based fluorescent nanomaterials having theranostic potentials: A combined experimental and theoretical studyCarbon Trends, 2021
- GOPY: A tool for building 2D graphene-based computational modelsSoftwareX, 2020
- Tuning range-separated DFT functionals for modeling the peak absorption of MEH-PPV polymer in various solventsComputational and Theoretical Chemistry, 2019
- Pharmacokinetics of huperzine A following oral administration to human volunteersEuropean Journal of Drug Metabolism and Pharmacokinetics, 2007